Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06373289
NA

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonary hypertension of which 50% of children will die before the age of 2. Physicians are currently limited in their ability to select the most appropriate oxygen targets that will improve outcomes in infants with this condition. This clinical trial will determine whether using different amounts of oxygen improve outcomes in infants with this disease.

Official title: Target Oxygen Saturation Ranges in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

Key Details

Gender

All

Age Range

1 Month - 5 Months

Study Type

INTERVENTIONAL

Enrollment

39

Start Date

2026-04

Completion Date

2030-07-01

Last Updated

2026-03-27

Healthy Volunteers

Yes

Interventions

DEVICE

higher oxygen saturation target using Nellcor pulse oximetry sensors

The intervention will be a cross over exposure to the higher oxygen saturation target.

DEVICE

lower oxygen saturation target using Nellcor pulse oximetry sensors

The intervention will be a cross over exposure to the lower oxygen saturation target.

Locations (2)

The University of Alabama at Birmingham

Birmingham, Alabama, United States

Yale New Haven Hospital

New Haven, Connecticut, United States